Morgan Stanley lowered the firm’s price target on AP Moller Maersk (AMKBY) to DKK 14,500 from DKK 14,800 and keeps an Equal Weight rating ...
AbbVie (NYSE:ABBV) has agreed to acquire all outstanding equity of neuroscience-focused biotech Aliada Therapeutics for $1.4B ...
JPMorgan raised the firm’s price target on AP Moller Maersk (AMKBY) to DKK 9,000 from DKK 8,575 and keeps an Underweight rating on the ...